The role of IL-12 in the induction of late-phase cellular infiltration in a murine model of allergic conjunctivitis

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 2 II, 2000, Pages 299-308

  Magone, M Teresa ^a   Whitcup, Scott M ^a   Fukushima, Atsuki ^a,b   Chan, Chi Chao ^a   Silver, Phyllis B ^a   Rizzo, Luizvicente ^a,c  

^a NATIONAL EYE INSTITUTE   (United States)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Allergic conjunctivitis; Cytokine deficient mice; IFN ; IL 12; IL 4

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; RAGWEED ANTIGEN; RECOMBINANT INTERLEUKIN 12;

ALLERGIC CONJUNCTIVITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMEDIATE TYPE HYPERSENSITIVITY; KNOCKOUT MOUSE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL MOVEMENT; CONJUNCTIVITIS, ALLERGIC; CYTOKINES; DISEASE MODELS, ANIMAL; HYPERSENSITIVITY, IMMEDIATE; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLLEN; TH2 CELLS; TIME FACTORS;

EID: 0033970379     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(00)90080-0     Document Type: Article

References (63)

1. Trocme SD, Raizman MB, Bartley GB. Medical therapy for ocular allergy. Mayo Clin Proc 1992;67:557-65.
2. Ehlers WH, Donshik PC. Allergic ocular disorders: a spectrum of diseases. Clao J 1992;18:117-24.
3. Foster CS. The pathophysiology of ocular allergy: current thinking. Allergy 1995;50:6-9; discussion 34-8.
4. Reiss J, Abelson MB, George MA, Wedner HJ. Allergic conjunctivitis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. St Louis: Mosby; 1996:345-58.
5. Bonini S, Vecchione A, Naim DM, Allansmith MR, Balsano F. Inflammatory changes in conjunctival scrapings after allergen provocation in humans. J Allergy Clin Immunol 1988;82:462-9.
6. Abelson MB, Udell IJ, Weston JH. Conjunctival eosinophils in compound 48/80 rabbit model. Arch Ophthalmol 1983;101:631-3.
7. Anderson DF, MacLeod JD, Baddeley SM, et al. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration. Clin Exp Allergy 1997;27:1060-6.
8. Nakajima H, Iwamoto I, Tomoe S, et al. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992;146:374-7.
9. Gavett SH, Chen X, Finkelman F, Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 1994;10:587-93.
10. Kung TT, Stelts D, Zurcher JA, et al. Mast cells modulate allergic pulmonary eosinophilia in mice. Am J Respir Cell Mol Biol 1995;12:404-9.
11. Belser RB, Fine ED, Boehm KD. Role of tumor necrosis factor and granulocyte-macrophage colony-stimulating factor in the late allergic response in human nasal mucosa. Otolaryngol Head Neck Surg 1996;114:418-23.
12. Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor. J Immunol 1998;160:5554-62.
13. Lack G, Bradley KL, Hamelmann E, et al. Nebulized IFN-g inhibits the development of secondary allergic responses in mice. J Immunol 1996;157:1432-9.
14. Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993;148:1102-4.
15. Gavett SH, O'Hearn DJ, Li X, Huang S-K, Finkelman FD, Wills-Karp M. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-36.
16. Hamid QA, Schotman E, Jacobson MR, Walker SM, Durham SR. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after sucessful grass pollen immunotherapy. J Allergy Clin Immunol 1997;99:254-60.
17. Kips JC, Brusselle GJ, Joos GF, et al. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1996;153:535-9.
18. Schwarze J, Hamelmann E, Cieslewicz G, et al. Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice. J Allergy Clin Immunol 1998;102:86-93.
19. van der Pouw Kraan TCTM, Boeije LCM, de Groot ER, et al. Reduced production of IL-12 and IL-12 dependent IFN-g release in patients with allergic asthma. J Immunol 1997;158:5560-5.
20. Keane-Myers A, Wysocka M, Trinchieri G, Wills-Karp M. Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12. J Immunol 1998;161:919-26.
21. Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 1992;90:262-6.
22. Xu H, Rizzo LV, Caspi RR. IL-12 induces growth of the IL-4-dependent CT4S line and has a synergistic effect on IL-4-induced CT4S proliferation. J Immunol Methods 1995;181:245-51.
23. Wu CY, Demeure CE, Gately M, et al. In vitro maturation of human neonatal CD4 T lymphocytes, I: induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J Immunol 1994;152:1141-53.
24. Magone MT, Rizzo LV, Chan CC, Kozhich AT, Whitcup SM. A new murine model of allergic conjunctivitis. Clin Immunol Immunopathol 1998;87:75-84.
25. Magram J, Connaughton SE, Warrier RR, et al. IL-12 deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996;4:471-81.
26. Rizzo LV, Miller-Rivero NE, Chan CC, Wiggert B, Nussenblatt RB, Caspi RR. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J Clin Invest 1994;94:1668-72.
27. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. New York: John Wiley; 1991.
28. Rizzo LV, De Kruyff RH, Umetsu DT, Caspi RR. Regulation of the interaction between Th1 and Th2 T cell clones to provide help for antibody production in vivo. Eur J Immunol 1995;25:708-16.
29. Aebischer I, Stadler BM. Th1-Th2 cells in allergic responses. Adv Immunol 1996;61:341-403.
30. Romagnani S. The Th1/Th2 paradigm. Immunol Today 1997;18:263-6.
31. Galli SJ, Lantz CS. Allergy. In: Paul WE, editor. Fundamental immunology. 4th ed. Philadelphia: Lippincott-Raven; 1998. p 1123-74.
32. Tomoe S, Iwamoto I, Yoshida S, Tomioka H. The in vivo depletion of CD4+ T cells prevents antigen-induced eosinophil infiltration into mouse skin. Arerugi 1992;41:699-703.
33. Sur S, Lam J, Bouchard P, Sigounas A, Holbert D, Metzger J. Immunomodulatory effects of IL-12 on allergic lung inflammation dependent on timing of doses. J Immunol 1996;157:4173-80.
34. Broide D, Schwarze J, Tighe H, et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998;161:7054-62.
35. Brusselle GG, Kips JC, Peleman RA, et al. Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12. Am J Respir Cell Mol Biol 1997;17:767-71.
36. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175-83.
37. Shi H, Zhong X, Long X, Chen Y. Effect of interferon-gamma on antigen-induced eosinophil infiltration into the mouse airway. Chin Med J (Engl) 1996;109:215-8.
38. Jones LS, Rizzo LV, Agarwal RK, et al. IFN-gamma deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol 1997;158:5997-6005.
39. Rizzo LV, Secord EA, Tsiagbe VK, et al. Components essential for the generation of germinal centers. Dev Immunol 1998;6:325-30.
40. Rizzo LV. Differential modulatory effect of IL-5 on MHC class II expression by macrophages and B cells. Braz J Med Biol Res 1992;25:509-13.
41. Hingorani M, Calder V, Jolly G, Buckley RJ, Lightman SL. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol 1998;102:821-30.
42. Makino S, Fukuda T. Eosinophils and allergy in asthma. Allergy Proc 1995;16:13-21.
43. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:258-65.
44. Ruede E, Schmitt E, Germann T. IL-12 and its receptor. In: Delves PJ, Roitt IM, editors. Encyclopedia of immunology. Vol 3. San Diego: Academic Press; 1998. p 1483-8.
45. Vezzio N, Sarfati M, Yang L-P, Demeure CE, Delespesse G. Human Th2-like cell clones induce IL-12 production by dendritic cells and may express several cytokine profiles. Int Immunol 1996;8:1963-70.
46. Bliss J, Van Cleave V, Murray K, et al. IL-12 as an adjuvant, promotes a T helper 1 cell, but does not suppress a t helper 2 cell recall response. J Immunol 1996;156:887-94.
47. Wakeham J, Wang J, Magram J, et al. Lack of both types 1 and 2 cytokines, tissue inflammatory responses and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice. J Immunol 1998;160:6101-11.
48. Yokoi H, Kato K, Kezuka T, et al. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12. Eur J Immunol 1997;27:641-6.
49. Tarrant TK, Silver PB, Chan CC, Wiggert B, Caspi RR. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J Immunol 1998;161:122-7.
50. Hamelmann E, Vella AT, Oshiba A, Kappler JW, Marrack P, Gelfand EW. Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc Natl Acad Sci USA 1997;94:1350-5.
51. Van der Pow Kraan TCTM, Snijders A, Boeije LCM, Alewijnse AE, Leurs R, Aarden LA. Histamine inhibits the production of IL-12 through interaction with H-2 receptors. J Clin Invest 1998;102:1866-73.
52. Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998;161:2586-93.
53. Krouwels FH, Hol BEA, Lutter R, et al. Histamine affects interleukin-4, interleukin-5, and interferon-gamma production by human T cell clones from the airways and blood. Am J Respir Cell Mol Biol 1998;18:721-30.
54. Sato J, Asakura K, Murakami M, Uede T, Kataura A. Topical CTLA4-Ig suppresses ongoing mucosal immune response in presensitized murine model of allergic rhinitis. Int Arch Allergy Immunol 1999;119:197-204.
55. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999;162:5070-7.
56. Pene J, Rousset F, Briere F, et al. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells: the role of soluble CD23 antigen. Eur J Immunol 1988;18:929-35.
57. Brusselle G, Kips J, Joos G, Bluethmann H, Pauwels R. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am J Respir Cell Mol Biol 1995;12:254-9.
58. von der Weid T, Kopf M, Kohler G, Langhorne J. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol 1994;24(:2285-93.
59. Noben-Trauth N, Kropf P, Muller I. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996;271:987-90.
60. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PJ. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997;99:1329-39.
61. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P. Active anaphylaxis in IgE-deficient mice. Nature 1994;370:367-70.
62. Mehlhop PD, van de Rijn M, Goldberg AB, et al. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc Natl Acad Sci USA 1997;94:1344-9.
63. Takeda K, Hamelmann E, Joetham A, et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997;186:449-54.